# Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors

> **NCT00116857** · PHASE3 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 122 (actual)

## Conditions studied

- Cardiovascular Diseases
- Depression
- Heart Diseases
- Myocardial Infarction
- Angina, Unstable

## Interventions

- **DRUG:** Sertraline/omega-3
- **DRUG:** Sertraline/Corn Oil

## Key facts

- **NCT ID:** NCT00116857
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2009-06
- **Final completion:** 2009-11
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2012-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116857, "Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00116857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*